Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
Benjamin Israelow(Yale University), Matthew J. Evans(Icahn School of Medicine at Mount Sinai), Marion Sourisseau(Icahn School of Medicine at Mount Sinai), Andres Y. Maldonado(Icahn School of Medicine at Mount Sinai), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Gavriel Mullokandov(Icahn School of Medicine at Mount Sinai), Judith Agudo(Dana-Farber Cancer Institute), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Ali Bashir(Icahn School of Medicine at Mount Sinai)
Cited by 72
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
Diverse functional autoantibodies in patients with COVID-19
|Nature|2021|984